{"pub": "financialpost", "url": "https://globenewswire.com/news-release/2019/10/18/1931806/0/en/Auxly-Announces-Proposed-Reduction-to-Conversion-Price-of-6-Unsecured-Convertible-Debentures-Due-January-16-2020.html", "downloaded_at": "2019-10-18 11:39:39.104097+00:00", "title": "Auxly Announces Proposed Reduction to Conversion Price of 6% Unsecured Convertible Debentures Due January 16, 2020", "language": "en", "text": "TORONTO, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (\u201cAuxly\u201d or the \u201cCompany\u201d) today announced that it has received approval from the TSX Venture Exchange (the \"TSXV\") to amend the conversion price under its 6% unsecured convertible debentures in the principal amount of $100,000,000 maturing on January 16, 2020 (the \"Debentures\") from $1.55 per share to $0.74 per share.\n\n\n\nThe Company will provide written notice (the \"Notice\") to holders of Debentures advising them of the proposed reduction in the conversion price and providing holders with the opportunity to immediately convert the principal amount of their Debentures at the revised conversion price. If a holder consents to the reduction in the conversion price but fails to elect to convert the outstanding principal amount of its Debenture within the time specified in the Notice, the Company will have the right to prepay all or any portion of the outstanding principal amount of a consenting holder's Debenture at any time on or prior to January 16, 2020. Should no Debentures be converted, Auxly has sufficient cash available to repay the Debentures when they come due.\n\nON BEHALF OF THE BOARD\n\n\"Hugo Alves\" CEO\n\nAbout Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF)\n\nAuxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries has secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading product research and development infrastructure in order to create trusted products and brands in an expanding global market.\n\nLearn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/.\n\nInvestor Relations:\n\nFor investor enquiries please contact our Investor Relations Team:\n\nEmail: IR@auxly.com\n\nPhone: 1.833.695.2414\n\nMedia Enquiries (only):\n\nFor media enquiries or to set up an interview please contact:\n\nSarah Bain, VP External Affairs\n\nEmail: sarah@auxly.com\n\nPhone: 613.230.5869\n\nNotice Regarding Forward Looking Information:\n\nThis news release contains certain \"forward-looking information\" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as \"plan\", \"continue\", \"expect\", \"project\", \"intend\", \"believe\", \"anticipate\", \"estimate\", \"may\", \"will\", \"potential\", \"proposed\" and other similar words, or information that certain events or conditions \"may\" or \"will\" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release.\n\nA number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release, including failure to obtain TSXV approval of the proposed amendments to the Debentures. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.\n\nNone of the securities referenced herein have been, or will be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements. This news release will not constitute an offer to sell or the solicitation of an offer to buy any securities and nor will there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.", "description": "", "authors": ["Auxly Cannabis Group Inc."], "top_image": "http://www.globenewswire.com/Attachment/LogoDisplay/544011?filename=544011.jpg&size=1", "published_at": "2019-10-18"}